A semisynthetic glycoconjugate provides expanded cross-serotype protection against Streptococcus pneumoniae.
Kaplonek P, Yao L, Reppe K, Voß F, Kohler T, Ebner F, Schäfer A, Blohm U, Priegue P, Bräutigam M, Pereira CL, Parameswarappa SG, Emmadi M, Ménová P, Witzenrath M, Hammerschmidt S, Hartmann S, Sander LE, Seeberger PH.
Kaplonek P, et al. Among authors: seeberger ph.
Vaccine. 2022 Feb 11;40(7):1038-1046. doi: 10.1016/j.vaccine.2021.12.068. Epub 2022 Jan 13.
Vaccine. 2022.
PMID: 35033388